tiprankstipranks
Merrimack Pharmaceuticals Inc. (MACK)
NASDAQ:MACK
US Market

Merrimack Pharmaceuticals (MACK) Ownership - Who Owns Merrimack Pharmaceuticals?

354 Followers

Merrimack Pharmaceuticals (MACK) Ownership Overview

74.52%8.78%8.98%7.71%
74.52% Insiders
8.98% Other Institutional Investors
7.71% Public Companies and
Individual Investors
The ownership structure of Merrimack Pharmaceuticals (MACK) stock is a mix of institutional, retail and individual investors. Approximately 17.76% of the company’s stock is owned by Institutional Investors, 74.52% is owned by Insiders and 7.71% is owned by Public Companies and Individual Investors.
The ownership structure of Merrimack Pharmaceuticals (MACK) stock is a mix of institutional, retail and individual investors. Approximately 17.76% of the company’s stock is owned by Institutional Investors, 74.52% is owned by Insiders and 7.71% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 28, 2023
Eric Andersen
Director,other
Bought$651754
Dec 11, 2023
Eric Andersen
Director,other
Bought$1297482
Nov 20, 2023
Eric Andersen
Director,other
Bought$3750
Nov 16, 2023
Eric Andersen
Director,other
Bought$627125

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$29133399

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,172,513Institution14.95%31,892,491
1,509,316Insider10.39%22,156,759
699,448Insider4.81%10,267,897
585,393Institution4.03%8,593,569
521,526Institution3.59%7,656,002
422,543Insider2.91%6,202,931
360,090Institution2.48%5,286,121
324,693Institution2.23%4,766,493
276,798Institution1.90%4,063,397
215,143Insider1.48%3,158,299

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
521,526Institution3.59%7,656,002
324,693Institution2.23%4,766,493
134,870Institution0.93%1,979,892
109,220Institution0.75%1,603,350
42,788Institution0.29%628,128
32,500Institution0.22%477,100
29,628Institution0.20%434,939
15,658Institution0.11%229,859
13,719Institution0.09%201,395
9,104Institution0.06%133,647

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
318,613Institution2.19%4,705,914
267,829Institution1.84%3,931,730
248,297Institution1.71%3,645,000
203,398Institution1.40%3,004,188
88,706Institution0.61%1,302,204
48,110Institution0.33%706,255
39,943Institution0.27%589,958
23,087Institution0.16%338,917
16,330Institution0.11%239,724
13,569Institution0.09%199,193

FAQ

Who Owns Merrimack Pharmaceuticals Inc. (MACK)?
According to the latest TipRanks data, approximately 8.98% of the company's stock is held by institutional investors, 74.52% is held by insiders, and 7.71% is held by retail investors.
    What percentage of Merrimack Pharmaceuticals Inc. (MACK) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 8.98% of Merrimack Pharmaceuticals Inc. (MACK) stock is held by institutional investors.
      What percentage of Merrimack Pharmaceuticals Inc. (MACK) stock is held by retail investors?
      According to the latest TipRanks data, approximately 7.71% of Merrimack Pharmaceuticals Inc. (MACK) stock is held by retail investors.
        Who owns the most shares of Merrimack Pharmaceuticals Inc. (MACK)?
        Eric Andersen owns the most shares of Merrimack Pharmaceuticals Inc. (MACK).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis